BIRC5 and neoplasm: The relationship between BIRC5 expression levels and the clinicopathological characteristics of patients with different tumors was analyzed based on stage pathology grade, tumor mutation burden (TMB), and microsatellite instability (MSI) status of tumor samples from the TCGA database.